Clinical Trial Update: An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. [Phase 4]

View source ↗

Summary

This update notes the completion of an open-label Phase 4 trial evaluating metformin for weight control in pediatric patients on antipsychotic medications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Cambridge Health Alliance | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED